Oral inhalation of cannabidiol delivered from a metered dose inhaler to alleviate cytokine production induced by SARS-CoV-2 and pollutants

Cannabidiol (CBD) was formulated as a metered dose inhaler (CBD-MDI) and evaluated in vitro for its efficacy as an inhaled dosage form against inflammation caused by the SARS-CoV-2 virus, lipopolysaccharide (LPS) from Escherichia coli, silica particles, nicotine, and coal tar. A CBD-MDI formulation...

Descripción completa

Detalles Bibliográficos
Autores principales: Srichana, Teerapol, Chunhachaichana, Charisopon, Suedee, Roongnapa, Sawatdee, Somchai, Changsan, Narumon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482090/
https://www.ncbi.nlm.nih.gov/pubmed/36159727
http://dx.doi.org/10.1016/j.jddst.2022.103805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482090/
https://www.ncbi.nlm.nih.gov/pubmed/36159727
http://dx.doi.org/10.1016/j.jddst.2022.103805

Ejemplares similares